logo

Neurocrine Biosciences Inc (NBIX)



Trade NBIX now with
  Date
  Headline
3/2/2021 7:36:35 AM Neurocrine Biosciences Says Luvadaxistat Did Not Meet Primary Endpoint In Phase II INTERACT Study
2/4/2021 4:04:24 PM Neurocrine Biosciences Q4 EPS $3.58 Vs. $0.35 Year Ago
1/8/2021 7:33:49 AM Neurocrine Biosciences Preliminary 2020 INGREZZA Net Product Sales And TRx Both Up 32% To About $993 Mln
11/10/2020 7:14:30 AM William Blair Is Cutting Neurocrine Biosciences Inc (NBIX) FY22 Rev. Estimate To 1.44 Billion From 1.87 Billion
11/10/2020 7:14:11 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY21 Rev. Estimate To 1.16 Billion From 1.49 Billion
11/10/2020 7:13:58 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY20 Rev. Estimate To 1.06 Billion From 1.15 Billion
11/10/2020 7:13:30 AM William Blair Is Cutting Neurocrine Biosciences Inc (NBIX) FY22 Estimate To 4.41 From 7.14
11/10/2020 7:13:03 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY21 Estimate To 3.66 From 5.85
11/10/2020 7:12:45 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY20 Estimate To 4.11 From 4.81
11/10/2020 7:11:59 AM William Blair Reiterates Neurocrine Biosciences Inc (NBIX) At Outperform
11/9/2020 4:03:48 PM Neurocrine Biosciences Q3 Loss/share $0.62 Vs. Profit $0.56 Year Ago
10/7/2020 6:51:24 AM Neurocrine Biosciences And Me2/Orchestra Team Up With Mental Health Advocacy Community To Launch Monumental Moments